Quốc gia: Canada
Ngôn ngữ: Tiếng Anh
Nguồn: Health Canada
CYPROTERONE ACETATE; ETHINYL ESTRADIOL
PALADIN LABS INC.
G03HB01
CYPROTERONE AND ESTROGEN
2MG; 0.035MG
TABLET
CYPROTERONE ACETATE 2MG; ETHINYL ESTRADIOL 0.035MG
ORAL
21
Prescription
OTHER MISCELLANEOUS THERAPEUTIC AGENTS
Active ingredient group (AIG) number: 0232337001; AHFS:
APPROVED
2007-03-01
______________________________________________________________________________________________ _ _CYESTRA-35 Product Monograph Page 1 of 48 _ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR CYESTRA ® -35 cyproterone acetate and ethinyl estradiol tablets 2 mg/0.035 mg THERAPEUTIC CLASSIFICATION Acne Therapy Paladin Labs Inc. Date of Preparation: 100 Alexis Nihon Blvd, Suite 600 January 17, 2019 St-Laurent, Quebec Version: 6.0 H4M 2P2 Control # 223341 ______________________________________________________________________________________________ _ _CYESTRA-35 Product Monograph Page 2 of 48 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ..................................................................3 SUMMARY PRODUCT INFORMATION ......................................................................................3 INDICATION AND CLINICAL USE ..............................................................................................3 CONTRAINDICATIONS ...............................................................................................................3 WARNINGS AND PRECAUTIONS ...............................................................................................4 ADVERSE REACTIONS.............................................................................................................. 13 DRUG INTERACTIONS .............................................................................................................. 16 DOSAGE AND ADMINISTRATION ......................................................................................... 20 OVERDOSAGE ........................................................................................................................... 22 ACTION AND CLINICAL PHARMACOLOGY ........................................................................... 22 STORAGE AND STABILITY ...................................................................................................... 24 SPECIAL HANDLING INSTRUCTIONS ............................ Đọc toàn bộ tài liệu